DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.